Aaron Freidin Sells 1,816 Shares of Grail, Inc. (NASDAQ:GRAL) Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Grail Stock Performance

NASDAQ GRAL opened at $26.92 on Friday. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The stock’s 50 day moving average is $31.60 and its 200 day moving average is $21.19.

Grail (NASDAQ:GRAL) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, equities analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Institutional Investors Weigh In On Grail

Hedge funds have recently made changes to their positions in the company. FNY Investment Advisers LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $26,000. Lindbrook Capital LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $28,000. State of Tennessee Department of Treasury bought a new stake in Grail in the fourth quarter worth $28,000. Sterling Capital Management LLC bought a new stake in Grail in the fourth quarter worth $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in Grail in the fourth quarter worth $33,000.

Wall Street Analysts Forecast Growth

GRAL has been the topic of several research analyst reports. Wolfe Research initiated coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley initiated coverage on Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.